Navigation Links
Orchid Cellmark Reports Second Quarter 2008 Financial Results
Date:7/31/2008

- U.S. Business Shows 9% Increase In Revenues -

- Florida Upholds Contract Award To Orchid Cellmark For Multi-Year

Paternity Testing -

- Regional Tender Work Underway In U.K. -

PRINCETON, N.J., July 31 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (Nasdaq: ORCH), a leading worldwide provider of identity DNA testing services, today reported its financial results for the second quarter of 2008.

Total revenues were $15.2 million for the second quarter of 2008 compared to $15.7 million for the second quarter of 2007 and $14.5 million for the first quarter of 2008. The decrease in total revenues for the second quarter of 2008 compared to the second quarter of 2007 was largely due to lower revenues in the U.K.

Orchid Cellmark recorded increases in its U.S. business that generates DNA profiles for the federal CODIS (Combined DNA Index System) and state DNA databases and in its U.S. paternity testing business, partially offset by lower revenues from its U.S. forensic casework business. Overall, U.S. revenues increased by 9% over the comparable quarter in 2007, largely as a result of the ReliaGene acquisition. The decrease in U.K.-based revenues in the second quarter of 2008, compared to the comparable period in 2007, was due to lower volumes of animal DNA testing for scrapie susceptibility and immigration identity testing, as well as reduced forensic revenue. The decrease was partially offset by increased revenues in the paternity testing business. Lower revenue for the U.K. forensics business was primarily due to the loss of revenue from the company's previous arrangement with LGC, which essentially ended in April 2008, as previously reported.

Excludin
'/>"/>

SOURCE Orchid Cellmark Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Orchid Cellmark To Announce Second Quarter 2008 Financial Results on July 31, 2008
2. Orchid Cellmark Reports First Quarter 2008 Financial Results
3. Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services
4. Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results
5. Orchid Cellmark to Announce Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
6. Orchid Cellmark Appoints William J. Thomas Vice President and General Counsel
7. Orchid Cellmark Reports Third Quarter 2007 Financial Results
8. Nutraceutical Reports Q3 Results
9. CVS Caremark Reports Record Second Quarter Revenues, Operating Profit, and Earnings
10. Diabetes For Dummies, 3rd Edition, Reports on the Latest Developments in the Field
11. Consumer Reports Healths Cover America Tour Chronicles Americans Anxiety Over Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... in massive health care spending, a new RAND study ... to incentivize pharmaceutical companies and device makers to develop ... existing medical technologies and their use, a new study ... and medical devices get created in the first place. ... with as little loss of health as possible and ...
(Date:4/22/2014)... Mich. Nearly 7 in 10 Americans support ... new national survey by researchers at the University of ... children under the age of 18 at home, and ... likely than other adults to support universal coverage of ... in the Journal of the American Medical Association ...
(Date:4/22/2014)... This news release is available in German . ... F. Perutz Laboratories of the University of Vienna and the ... Zurich, have now shown how double stranded RNA, such as ... a cell. During the immune response against viral infection, the ... cytoplasm. There it modifies viral RNA to inhibit reproduction of ...
(Date:4/22/2014)... When mothers are exposed to trauma, illness, alcohol or ... molecular trigger in brain cells that can go awry ... and some forms of autism. , Until now, it ... the cells of a developing brain. Past studies have ... alcohol or drug abuse or she experiences some trauma ...
(Date:4/22/2014)... chronic inflammatory disorders of the intestine that result in ... in the U.S., and while there are treatments to ... , Now, Cincinnati Cancer Center and University of Cincinnati ... in her lab have done what is believed to ... important function for the Ron receptor, a cell surface ...
Breaking Medicine News(10 mins):Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3Health News:More than two-thirds of Americans support mandated coverage of birth control in health plans 2Health News:How the body fights against viruses 2Health News:How the body fights against viruses 3Health News:Life stressors trigger neurological disorders, researchers find 2Health News:Two genes linked to inflammatory bowel disease 2
... the only over the counter treatment for chronic and acute wounds. ... contamination of wounds and speeds up the healing process. ... ... development of Wound-Be-Gone, all skin injuries, especially large, chronic wounds, can ...
... WASHINGTON, Nov. 18 Over 2 million low-income Medicare,beneficiaries ... in,January. Changes to the 2009 Medicare Part D plans ... premiums they cannot afford or limit,access to their prescriptions, ... Law Center (NSCLC). Part D open enrollment runs from ...
... But research is preliminary, scientists stress , , TUESDAY, Nov. ... a genetic trait that could provide an early indication ... The research, reported Tuesday at the American Association for ... the preliminary stages. , Still, "the benefit would hopefully ...
... A study appearing in Journal of the American ... their healthcare benefits may affect their ability to access ... delay or avoid seeking care. , In the ... across the United States were surveyed. About one-third of ...
... Resource So Families of ,Bad, Children Can Survive - and ... BEACH, Fla., Nov. 18 The holidays should bring peace, ... the season can foster difficult, even disorderly conduct among troubled ... a family gathering and leave parents asking, "What did I ...
... SEATTLE, Nov. 18 Seattle University ... million Opus Prize to Marguerite "Maggy",Barankitse for her ... of,ethnic strife in Burundi, Africa. Two $100,000 winners ... Community and Center for the,Development of Central America, ...
Cached Medicine News:Health News:A Revolution in Wound Healing, Wound-Be-Gone Now the Only Over the Counter Treatment for Chronic and Acute Wounds 2Health News:A Revolution in Wound Healing, Wound-Be-Gone Now the Only Over the Counter Treatment for Chronic and Acute Wounds 3Health News:2009 Medicare Part D Premiums to Rise Dramatically: Over 2 Million Low Income Beneficiaries At Risk 2Health News:Genetic Trait Could Predict Lung Cancer 2Health News:New Site DrNorm.com Offers Hope and Healing to Parents of 'Difficult' Children During Holiday Season & Beyond 2Health News:New Site DrNorm.com Offers Hope and Healing to Parents of 'Difficult' Children During Holiday Season & Beyond 3Health News:Seattle University in Partnership With the Opus Prize Foundation Award $1 Million Opus Prize 2
(Date:1/15/2014)... 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ... stock of Solta Medical, Inc. (NASDAQ: SLTM ...
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... results for the fourth quarter of 2013 on Monday, February ... for release after the close of trading. ... conference call to discuss the operating highlights and financial results ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
... (NYSE: DHR ) announced today that Henk ... and Amir Aghdaei and Henrik Roos have each been ... In his new role, Henk van Duijnhoven will ... Group and Sybron Dental Specialties.  Danaher,s Dental segment generated ...
... ALISO VIEJO, Calif., April 5, 2011 Avanir Pharmaceuticals, Inc. ... will present an overview of the company at the Future Leaders ... Location: Millennium Broadway Hotel & Conference Center, New York, ... Presentation time: 2:00pm ET A live ...
Cached Medicine Technology:Danaher Announces Executive Appointments 2
Complete Cataract Competence , OPMI VISU 140 is compact, good and economical. It's everything a cataract specialist needs today....
BD Vacutainer® Specialty Tubes - Acid Citrate Dextrose (ACD)...
... BD Vacutainer® SST™ Tubes ... a polymer gel for ... used for serum determinations ... provide an efficient means ...
MONOJECT Red/Yellow Mottled Stopper...
Medicine Products: